XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
  Immunization
   Vaccination
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Vaccination Channel
subscribe to Vaccination newsletter

Latest Research : Public Health : Immunization : Vaccination

   DISCUSS   |   EMAIL   |   PRINT
Vaccine developed against dust mite allergy
Apr 27, 2006 - 1:42:00 PM, Reviewed by: Dr. Priya Saxena

The company injected 19 patients to check the safety and efficacy of its vaccine. Of them, 17 were found to be completely tolerant to the mites, with no allergic reactions.

 
A Swiss company has developed a vaccine that it claims could be effective against dust mite allergy.

Cytos, one of a number of firms developing anti-allergen vaccines, carried out a study of the new vaccine and found significant benefits against dust mite allergy.

The vaccine consists of an empty virus filled with DNA designed to trigger a response from the immune system attached to a protein from the dust mite excrement - the allergen - which would usually cause an allergic reaction, reported the online edition of BBC News.

It is designed to boost the activity of the immune system to suppress that allergic reaction, the company said.

The company injected 19 patients to check the safety and efficacy of its vaccine. Of them, 17 were found to be completely tolerant to the mites, with no allergic reactions. They experienced far fewer allergy symptoms such as sneezing while asthmatics did not have attacks.

The dust mites - oval shaped, cream coloured, eight-legged creatures - are so small they cannot be seen with the naked eye.

The mites, which survive on scales of human skin, finger nails, hair, pollen, fungi and bacteria can be found even at clean homes, offices and many other places. They themselves are not allergenic, but the proteins they produce are.

They are one of the most common causes of perennial asthma and allergy symptoms.
 

- Indo-Asian News Service
 

 
Subscribe to Vaccination Newsletter
E-mail Address:

 



Related Vaccination News

New Non-Invasive Vaccine Strategy May Offer Protection Against Tetanus and Anthrax
Vaccine developed against dust mite allergy
Rotavirus vaccine will protect children against a major killer worldwide
World's First Plant-made Vaccine Registered
A solution to increase the efficacy of vaccines
Large Study Finds No Link Between Multiple Childhood Vaccinations And Subsequent Hospitalization For Nontargeted Diseases


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us